WATERS CORPORATION Reports Second Quarter Earnings for Fiscal Year 2023
August 6, 2023
🌥️Earnings Overview
On June 30, 2023, WATERS CORPORATION ($NYSE:WAT) published its earnings report for the second quarter of fiscal year 2023, showing total revenue of USD 740.6 million, a 3.7% increase from the same period of the previous year. However, reported net income was USD 150.6 million, an 8.7% decrease from the year before.
Price History
The stock opened at $282.0 and closed at $291.8, representing a 6.3% increase from the previous closing price of $274.4. The company’s earnings report showed a significant increase in revenue and profits year-over-year. Overall, WATERS CORPORATION‘s second quarter earnings report was positive, with significant increases in both revenue and profits year-over-year.
The stock market reacted favorably to this news, with the stock price increasing 6.3% on Wednesday. With its strong financials and robust share repurchase program, WATERS CORPORATION looks well-positioned for continued growth in the future. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Waters Corporation. More…
| Total Revenues | Net Income | Net Margin |
| 2.99k | 674.54 | 22.5% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Waters Corporation. More…
| Operations | Investing | Financing |
| 571.67 | -1.47k | 799.51 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Waters Corporation. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 4.55k | 3.78k | 13.06 |
Key Ratios Snapshot
Some of the financial key ratios for Waters Corporation are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 9.5% | 10.4% | 29.0% |
| FCF Margin | ROE | ROA |
| 12.9% | 79.2% | 11.9% |
Analysis
GoodWhale has conducted an analysis of WATERS CORPORATION‘s wellbeing, and the results of our Star Chart measurement indicate that the company is strong in profitability, medium in growth, and weak in asset and dividend. Our health score for WATERS CORPORATION is 9/10, indicating that the company is capable of paying off debt and funding future operations. Based on this analysis, we classify WATERS CORPORATION as a “rhino” – a type of company that has achieved moderate revenue or earnings growth. From an investment perspective, WATERS CORPORATION may be an attractive opportunity for investors looking for a stable stock that offers consistent returns. With its strong profitability and medium growth, it can provide steady income with potential for increases in the future. Additionally, its high health score means that the company is likely to remain financially sound and able to pay dividends to shareholders. More…
Peers
Waters Corporation is an American analytical instrument manufacturing company that specializes in liquid chromatography, mass spectrometry, and thermal analysis instruments. It has annual sales of over $2 billion and employs more than 6,000 people worldwide. Its products are used in the life sciences, pharmaceutical, and chemical industries. Waters Corporation’s main competitors are IQVIA Holdings Inc, Agilent Technologies Inc, Vijaya Diagnostic Centre Ltd.
– IQVIA Holdings Inc ($NYSE:IQV)
The company’s market cap as of 2022 was 39.27B and its ROE was 21.52%. The company is a global provider of information, innovative technology solutions, and real-world insights that help customers improve their well-being. The company offers a broad range of products and services that enable customers to manage their health and wellbeing.
– Agilent Technologies Inc ($NYSE:A)
Agilent Technologies, Inc. is a provider of life sciences, diagnostics, and applied chemical markets solutions. It operates through three segments: Life Sciences and Applied Markets Group, Diagnostics and Genomics Group, and Agilent CrossLab Group. The Life Sciences and Applied Markets Group segment offers application solutions that include chromatography, mass spectrometry, chemical analysis, and cellular analysis. The Diagnostics and Genomics Group segment provides in vitro diagnostic products and services. The Agilent CrossLab Group segment offers a range of services and consumables. Agilent Technologies was founded in 1999 and is headquartered in Santa Clara, California.
– Vijaya Diagnostic Centre Ltd ($BSE:543350)
Vijaya Diagnostic Centre Ltd is a leading diagnostic centre in India with a market cap of 46.61B as of 2022. The company has a return on equity of 17.7%. The company offers a wide range of diagnostic services including X-rays, ultrasounds, MRI, and CT scans. The company also has a wide network of centres across India.
Summary
WATERS CORPORATION reported their earnings for the second quarter of FY 2023, with total revenue reaching USD 740.6 million, up 3.7% year-over-year. Reported net income was USD 150.6 million, a decrease of 8.7% compared to the same period last year. Despite the decrease in net income, stock price moved up on the same day, indicating that investors are still positive about the company’s future prospects. Investors may want to watch the company’s performance and any changes in its revenue and net income going forward to make informed investing decisions.
Related Posts
Recent Posts
